Literature DB >> 20827020

Generalized papular and sclerodermoid eruption: scleromyxedema.

Zehra Asiran Serdar1, Ilknur Kivanc Altunay, Sirin Pekcan Yasar, Gamze Türker Erfan, Pembegül Gunes.   

Abstract

Scleromyxedema (SM) is a rare chronic progressive and highly intractable cutaneous disease with unknown etiology, affecting both genders equally between 30 and 50 years. The disease is characterized with mucin deposits in the skin and/or other organs. In fact it is a clinicopathological subset of lichen myxedematosus (LM) according to a new classification. Sclerodermiform plaques and lichenoid papules are characteristic cutaneous lesions. An elevation of IgG λ (lambda) chain exists in most cases and extracutaneous involvement occurring with variable systemic findings is also detected. Generalized form is quite difficult to treat and may even be fatal. Herein, we present a male patient with typical features of generalized papular and sclerodermoid LM variety and with benign outcome by isotretinoin.

Entities:  

Mesh:

Year:  2010        PMID: 20827020     DOI: 10.4103/0378-6323.69096

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  6 in total

Review 1.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

2.  Case for diagnosis. Lichen myxedematosus.

Authors:  Priscila Regina Orso Rebellato; Mauren Beatriz Frazon Carbonar; Nicole Iasmin Magario Tabuti; Graziela Junges Crescente Rastelli
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

3.  A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema.

Authors:  Oleksander Prylutskyi; Olga Prylutska; Anatoliy Degonskyi; Kseniia Tkachenko
Journal:  Ethiop J Health Sci       Date:  2016-09

4.  Scleromyxedema: a rare disorder and its treatment difficulties.

Authors:  Sandra Koleta Koronowska; Agnieszka Osmola-Mańkowska; Oliwia Jakubowicz; Ryszard Zaba
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

5.  Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report.

Authors:  Federica Arginelli; Franco Rongioletti; Giampiero Girolomoni; Giovanni Pellacani; Davide Guardoli; Andrea Conti
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

6.  Characterization of circulating myeloma tumor cells by next generation flowcytometry in scleromyxedema patient: a case report.

Authors:  Ruba Y Taha; Saba Hasan; Firyal Ibrahim; Yannick Chantran; Hesham El Sabah; Siveen Sivaraman; Issam Al Bozom; Ahmad Al Sabbagh; Laurent Garderet; Halima El Omri
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.